Tuesday, May 24, 2022
No Result
View All Result
Medical Finance
  • Home
  • News
  • Interviews
  • Mediknowledge
  • Insights From Industry
  • Thought Leaders
  • Coronavirus
  • Whitepapers
  • Home
  • News
  • Interviews
  • Mediknowledge
  • Insights From Industry
  • Thought Leaders
  • Coronavirus
  • Whitepapers
No Result
View All Result
Medical Finance
No Result
View All Result
Home Coronavirus

Comparison of neutralizing antibody response following SARS-CoV-2 booster vaccination with breakthrough infection

by Medical Finance
in Coronavirus
Study: Comparison of neutralizing antibody response following SARS-CoV-2 booster vaccination with breakthrough infection. Image Credit: spaxiax/Shutterstock
9
SHARES
99
VIEWS
Share on FacebookShare on Twitter

Since the onset of the Coronavirus Disease 2019 (COVID-19) pandemic, it has brought about episodic waves of increased infections due to the emergence of new severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants. These variants have higher transmissibility and resistance to immune responses that are elicited by the current vaccines.

Study: Comparison of neutralizing antibody response following SARS-CoV-2 booster vaccination with breakthrough infection. Image Credit: spaxiax/Shutterstock
Study: Comparison of neutralizing antibody response following SARS-CoV-2 booster vaccination with breakthrough infection. Image Credit: spaxiax/Shutterstock

The World Health Organization has classified the most epidemiologically important variants as variants of concern (VOC) which include Alpha, Beta, Delta, and Omicron.

Currently, the Omicron variant (including sub-lineages BA.1 and BA.2) is the predominant circulating variant throughout the world. The spike protein of the Omicron variant is reported to have 39 amino acid changes out of which approximately half fall within the receptor-binding domain (RBD) which binds to the human receptor angiotensin-converting enzyme 2 (ACE2). Since all known neutralizing antibodies mostly target the RBD, mutations within this region lead to severe loss in neutralizing activity of approved monoclonal antibody therapeutics.

Since antigenic exposure from boosters and breakthrough infections can boost serological immunity, third-dose vaccine booster campaigns are underway to control the ongoing Omicron wave. Although vaccine breakthrough infections can directly train the immune system against variant spike proteins, they are associated with medical risks. Booster vaccinations on the other hand are generally safe and effectively increase the neutralizing response against Omicron. However, the durability of responses due to boosting and breakthrough infection and whether they provide greater protection from reinfection with Omicron or future variants is unknown.

A new study posted to the pre-print server medRxiv* examined the serological immune responses and antibody-dependent cell-mediated phagocytosis in those individuals who had either received two doses of a standard vaccine regime, or a booster dose following the regime, or a breakthrough infection following vaccination.

About the study

The study involved two- and three-dose group participants as well as breakthrough participants. The two- and three-dose group participants had no COVID-19 history. For the breakthrough participants, a polymerase chain reaction (PCR) test was done to confirm SARS-CoV-2 infection. Blood samples were collected from all the participants for further analysis. The vaccine used in this stud was BNT162b2 (Pfizer) and only individuals with no immunocompromising conditions were included.

Thereafter, an enzyme-linked immunosorbent assay (ELISA) was performed followed by antibody-dependent cellular phagocytosis (ADCP). SARS-CoV-2 was then propagated in cell cultures and viral stock titers were calculated in focus forming units (FFU) that were based on dilution factor and volume used for infection. Finally, focus reduction neutralization test (FRNT) assays were performed.

Study findings

The results indicated that the half-maximal antibody binding in ELISA (EC50) to full-length SARS-CoV-2 spike was 223 percent higher in the three-dose group and 278 percent higher in the breakthrough group as compared to the two-dose group. The spike RBD-specific antibodies were found to increase in the three-dose group but not in the breakthrough group. The increase in spike RBD-specific antibodies was reported to be 259 percent higher in the three-dose group as compared to the two-dose group.

Additionally, the spike-specific IgG levels were found to be 224 percent and 261 percent higher and spike-specific IgA levels were found to be 221 percent and 279 percent higher in the three-dose and breakthrough groups respectively as compared to the two-dose group. However, the IgM levels did not differ significantly among the groups.

ADCP was also found to increase in the three-dose and breakthrough group as compared to the two-dose group. The geometric mean titers (GMT) that showed 50 percent neutralization of the original SARS-CoV-2 virus (WA1, Wuhan strain) were reported to be 463 percent and 732 percent higher for the three-dose and breakthrough groups as compared to the two-dose group. For Delta strain, the GMT was found to be 948 percent and 424 percent higher for the breakthrough and three-dose group as compared to the two-dose group. For the Omicron strain, the GMT was found to be 1156 percent and 1810 percent higher for the three-dose and breakthrough group as compared to the two-dose group.

Furthermore, the neutralizing titer was found to correlate strongly with the neutralization of WA1 and Delta strain. However, for the Omicron strain, the correlation was found to be weaker for the two-dose group. The neutralizing potency index (NPI) which is the ratio of live-virus neutralization to spike-specific antibody EC50 for WA1 was found to be 0.60 for the two-dose group, 1.10 for the three-dose group, and 1.91 for the breakthrough group. For Delta, it was found to be 0.30, 0.52, and 0.93 and for Omicron it was found to be 0.03, 0.15, and 0.20 for two-dose, three-dose, and breakthrough groups, respectively.

The ratio of neutralization for each variant to WA1 neutralization for Delta was found to be 0.42 for two-dose, 0.43 for three-dose, and 0.55 for the breakthrough group. For Omicron it was 0.06 for two-dose, 0.12 for three-dose, and 0.13 for the breakthrough group. Also, a negative correlation was found between age and WA1 neutralizing titer for the two-dose and three-dose groups but not for the breakthrough group.

The current study, therefore, demonstrates that the foundation of immunity can be further increased by boosting or breakthrough infections, even for immune-resistant variants such as Omicron. The increased immunity due to booster vaccinations or breakthrough infections throughout the world can thus lead to the acquirement of potent immune responses that can help to protect against the future SARS-CoV-2 variants.

*Important notice

medRxiv publishes preliminary scientific reports that are not peer-reviewed and, therefore, should not be regarded as conclusive, guide clinical practice/health-related behavior, or treated as established information.

Total
0
Shares
Share 0
Tweet 0
Pin it 0
Share 0
Medical Finance

Medical Finance

Related Posts

Study: Long-term detection of SARS-CoV-2 antibodies after infection and risk of re-infection. Image Credit: Corona Borealis Studio/Shutterstock

Antibodies against SARS-CoV-2 found to persist for up to 15 months after infection

by Medical Finance
May 24, 2022
0

In a new preproof study published in the latest issue of the International Journal of Infectious Diseases, a team of...

Small cluster of neurons in the brain stem found to coordinate vocalization with breathing

In super-vaxxed Vermont, covid strikes — but packs far less punch

by Medical Finance
May 24, 2022
0

Even Eden, a snow-covered paradise in northern Vermont, is poisoned by omicron. The nearly vertical ascent of new coronavirus cases...

Study: Continuing inequalities in COVID-19 mortality in England and Wales, and the changing importance of regional, over local, deprivation. Image Credit: suma2020/ Shutterstock

Observational study reveals continuing inequality in COVID-19 mortality in England and Wales

by Medical Finance
May 24, 2022
0

Researchers have conducted various experimental as well as observational studies to understand the nature and progress of the ongoing coronavirus...

Study: Durable T-cellular and humoral responses in SARS-CoV-2 hospitalized and community patients. Image Credit: Lightspring/Shutterstock

Immune responses in patients with varying degrees of SARS-CoV-2 infection

by Medical Finance
May 24, 2022
0

The novel severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2) primarily triggers an immune condition that affects multiple organ systems. The...

Study: Safety of COVID-19 vaccines in pregnancy: a Canadian National Vaccine Safety (CANVAS) Network study. Image Credit: Huseyin Eren Obuz/Shutterstock

Health events amongst pregnant females after COVID-19 vaccination

by Medical Finance
May 24, 2022
0

In a recent study posted to the medRxiv* preprint server, researchers evidenced that messenger ribonucleic acid (mRNA)-based coronavirus disease 2019...

Fire closes hospital and displaces staff as Colorado battles omicron

Biden administration announces boost for rural health care in midterm election push

by Medical Finance
May 24, 2022
0

As the midterm election season ramps up, the Biden administration wants rural Americans to know it'll be spending a lot...

Next Post
First patient-derived stem cell model developed for studying oculocutaneous albinism

New training scheme for convolutional neural networks automates cell segmentation and counting

Scientists identify a new switch for controlling motor proteins

Scientists discover how immune proteins defend plants against invading microorganisms

0 0 votes
Article Rating
Subscribe
Login
Notify of
guest
guest
0 Comments
Inline Feedbacks
View all comments

Support

  • Contact
  • Disclaimer
  • Home
  • Privacy Policy
  • Terms And Conditions

Categories

  • Coronavirus
  • Insights From Industry
  • Interviews
  • Mediknowledge
  • News
  • Thought Leaders
  • Whitepapers

More News

  • Study: SARS-CoV-2 Nsp1 N-terminal and linker regions as a platform for host translational shutoff. Image Credit: ATS / Shutterstock
    Mechanism of SARS-CoV-2 Nsp1 interaction with ribosomal complexes
  • Study: Prenatal and postpartum maternal mental health and neonatal motor outcomes during the COVID-19 pandemic. Image Credit: Buritora / Shutterstock
    Study examines relationship between prenatal and postnatal stress, depression, and infant motor development during COVID
  • Home
  • Privacy Policy
  • Contact
  • Disclaimer
  • Terms And Conditions

© 2022 Medical Finance - Latest Financial and Business News

No Result
View All Result
  • Interviews
  • Mediknowledge
  • News
  • Insights From Industry
  • Coronavirus
  • Thought Leaders
  • Whitepapers
wpDiscuz
0
0
Would love your thoughts, please comment.x
()
x
| Reply